Expanding molecular diagnostic coverage for tuberculosis by combining computer-aided chest radiography and sputum specimen pooling: a modeling study from four high burden countries

Author:

Codlin Andrew James1,Vo Luan Nguyen Quang1,Garg Tushar2,Banu Sayera3,Ahmed Shahriar3,John Stephen4,Abdulkarim Suraj4,Muyoyeta Monde5,Sanjase Nsala5,Wingfield Tom6,Iem Vibol6,Squire Bertie6,Creswell Jacob2

Affiliation:

1. Friends for International TB Relief

2. Stop TB Partnership

3. International Centre for Diarrhoeal Disease Research

4. Janna Health Foundation

5. Centre for Infectious Disease Research in Zambia

6. Liverpool School of Tropical Medicine

Abstract

Abstract Background In 2022, fewer than half of persons with tuberculosis (TB) have access to molecular diagnostic tests for TB due to their high costs. Studies have found that computer-aided detection using artificial intelligence (AI) for chest X-ray (CXR) and sputum specimen pooling can each reduce testing costs. We modeled the combination of both strategies to estimate potential savings in consumables that could be used to expand access to molecular diagnostics. Methods We obtained Xpert testing and positivity data segmented into deciles by AI probability scores for TB from community- and healthcare facility-based active case finding conducted in Bangladesh, Nigeria, Viet Nam and Zambia. AI scores in the model were based on CAD4TB version 7 (Zambia) and qXR (all other countries). We modeled four ordinal screening and testing approaches involving computer-aided CXR to indicate individual and pooled testing. Setting a false negative rate of 5%, for each approach we calculated additional and cumulative savings over the baseline of universal Xpert testing as well as the theoretical expansion in diagnostic coverage. Results In each country, the optimal screening and testing approach was to use AI to rule out testing in deciles with low AI scores and guide pooled and individual testing in persons with moderate and high AI scores, respectively. This approach yielded cumulative savings in Xpert tests over baseline ranging from 50.8% in Zambia to 57.5% in Nigeria and 61.5% in Bangladesh and Viet Nam. Using these savings, diagnostic coverage theoretically could be expanded by 34–160% across the different approaches and countries. Conclusions Using a combination of AI and CXR to inform different pooling strategies may optimize TB diagnostic test use, and could extend molecular tests to more people who need them. The optimal AI thresholds and pooled testing strategy varied across countries, which suggests that bespoke screening and testing approaches may be needed for differing populations and settings.

Publisher

Research Square Platform LLC

Reference42 articles.

1. GeneXpert—A Game-Changer for Tuberculosis Control?;Evans CA;PLoS Med,2011

2. Rapid Diagnosis of Mycobacterium tuberculosis with Truenat MTB: A Near-Care Approach;Nikam C;PLoS One,2013

3. Branigan D. Tuberculosis Diagnostics Pipeline Report » 2023. 2023.

4. World Health Organization. Global Tuberculosis Report 2023. Geneva, Switzerland; 2023.

5. World Health Organization. WHO standard: universal access to rapid tuberculosis diagnostics. Geneva, Switzerland: World Health Organization; 2023.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3